and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R ...

Imagine standing face to face with a giraffe, your neck craned back as you gaze up at this gentle giant towering over you. At ...

He expressed concern that every year in Nigeria, more than 12,000 women suffer from cervical cancer, saying the disease is preventable. Prof. Pate noted that President Bola Tinubu was committed to ...

Launched in 2023 to prevent cervical cancer, India’s first indigenous human papilloma virus (HPV) vaccine—Cervavac—has found only 63 takers in the 18-25 age group at the Post Graduate ...

A new report on cancer in the US shows a steady decline in overall deaths from 2001 through 2022. The rate of diagnoses among ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV.

PETALING JAYA: Cervical cancer is ranked as the fourth most common cancer affecting women in Malaysia, with 1,740 cases in 2020 of whom 991 or 57% succumbed to the disease, according to the Global ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

First Lady Oluremi Tinubu’s Renewed Hope Initiative (RHI) has announced a N1 billion donation to the fight against cervical cancer by the National Cancer Fund. The donation, which coincided with ...

Although Malaysia’s on-going efforts against cervical cancer were temporarily derailed by Covid-19 lockdowns, Dr Murallitharan said there is a strong commitment to get them back on track and ...

Keytruda (pembrolizumab) was given an accelerated approval in 2018 as a second-line therapy for PD-L1-positive cervical cancer, but the new survival data – from the phase 3 KEYNOTE-826 trial ...